Dudediligence.

Invivyd, Inc

IVVDNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$4,790,852

12 notices · 1,875,308 sh

Oct 2025 to Oct 2026

Reported ·

$354,534

10 sales · 1 buy · $125,000 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

All 10 reported sales carry the 10b5-1 box. Together they are 0.08% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-17: Lee Timothy Edward, Form 1442026-08-17: Green Julie, Form 1442026-08-17: Duke William E., Form 1442026-08-17: Andersen Jill, Form 1442026-08-17: Allen Robert D. III, Form 1442026-02-17: Green Julie, Form 1442026-02-17: Allen Robert D. III, Form 1442026-02-17: Lee Timothy Edward, Form 1442026-02-17: Duke William E., Form 1442026-02-17: Andersen Jill, Form 1442025-12-23: ADIMAB, LLC, Form 1442025-11-17: ADIMAB, LLC, Form 1442025-11-19: MCLAUGHLIN KEVIN F, bought2026-02-17: Andersen Jill, sold2026-02-17: Lee Timothy Edward, sold2026-02-17: Duke William E., sold2026-02-17: Green Julie, sold2026-02-17: Allen Robert D. III, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-08-17Lee Timothy Edward, Chief Commercial Officer$29,413
40,800 shplan 2025-02-20Form 4s on file end Jun 23144 ↗
2026-08-17Green Julie, Chief Human Resources Officer$29,413
40,800 shplan 2025-02-20Form 4s on file end Jun 23144 ↗
2026-08-17Duke William E., Chief Financial Officer$29,413
40,800 shplan 2025-02-20Form 4s on file end Jun 23144 ↗
2026-08-17Andersen Jill, Chief Legal Officer, Secretary$49,022
68,001 shplan 2025-02-20Form 4s on file end Jun 23144 ↗
2026-08-17Allen Robert D. III, Chief Scientific Officer$27,207
37,741 shplan 2025-02-20Form 4s on file end Jun 23144 ↗
2026-02-17Green Julie, Chief Human Resources Officer$61,776
39,600 shplan 2025-02-20144 ↗
Form 4, 2026-02-18: sold 40,627 at $1.56 Form 4 ↗
2026-02-17Allen Robert D. III, Chief Scientific Officer$57,143
36,630 shplan 2025-02-20144 ↗
Form 4, 2026-02-18: sold 37,581 at $1.56 Form 4 ↗
2026-02-17Lee Timothy Edward, Chief Commercial Officer$61,776
39,600 shplan 2025-02-20144 ↗
Form 4, 2026-02-18: sold 40,627 at $1.56 Form 4 ↗
2026-02-17Duke William E., Chief Financial Officer$61,776
39,600 shplan 2025-02-20144 ↗
Form 4, 2026-02-18: sold 40,627 at $1.56 Form 4 ↗
2026-02-17Andersen Jill, Chief Legal Officer, Secretary$102,960
66,000 shplan 2025-02-20144 ↗
Form 4, 2026-02-18: sold 67,710 at $1.56 Form 4 ↗
2025-12-23ADIMAB, LLC, 10% Stockholder$577,499
192,320 shno plan dateno Form 4 on file144 ↗
2025-11-17ADIMAB, LLC, 10% Stockholder$3,703,455
1,233,416 shno plan dateno Form 4 on file144 ↗